Cell-Cycle-Targeting MicroRNAs as Therapeutic Tools against Refractory Cancers
Per Hydbring(Harvard University), Piotr Siciński(Harvard University), Richard S. Swanson(Brigham and Women's Hospital), Kevin Kauffman(Massachusetts Institute of Technology), Katharine E. Sweeney(Harvard University), Shom Goel(Dana-Farber Cancer Institute), Lars Anders(Pfizer (United States)), Haluk Yuzugullu(Harvard University), Verónica Matía(Harvard University), Roman L. Bogorad(Massachusetts Institute of Technology), Daniel G. Anderson(Massachusetts Institute of Technology), Davide Floris(Harvard University), Jean J. Zhao(Harvard University), Ewa Sicińska(Harvard University), Anne Fassl(Harvard University), Junghoon Yang(Massachusetts Institute of Technology), Cheng Li(First Affiliated Hospital of Zhengzhou University), Kimmie Ng(Dana-Farber Cancer Institute), Hao Yin(Wuhan University), Yinan Wang(Peking University), Xiaoting Li(Tsinghua University), Tobias Otto(RWTH Aachen University), Chong Jin(Peking University), Yingxiang Li, Jan M. Suski(Instytut Biologii Doświadczalnej im. Marcelego Nenckiego), Yoon Jong Choi(Blueprint Medicines (United States)), Kornélia Polyák(Dana-Farber Cancer Institute)
Cited by 98
Related Papers
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
|Nature reviews. Cancer|2009|3.3k
Knocking down barriers: advances in siRNA delivery
|Nature Reviews Drug Discovery|2009|3.1k
The Genomic Landscapes of Human Breast and Colorectal Cancers
|Science|2007|2.8k